首页 | 本学科首页   官方微博 | 高级检索  
     


Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus–driven oropharyngeal cancer and are associated with recurrence
Authors:Krystle A. Lang Kuhs PhD  MPH  Aimée R. Kreimer PhD  Sumita Trivedi MD  Dana Holzinger PhD  Michael Pawlita MD  Ruth M. Pfeiffer PhD  Sandra P. Gibson BS  Nicole C. Schmitt MD  Allan Hildesheim PhD  Tim Waterboer PhD  MSc  Robert L. Ferris MD  PhD
Affiliation:1. National Cancer Institute, National Institutes of Health, Bethesda, Maryland;2. Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee;3. Department of Otolaryngology and Cancer Immunology Program, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania;4. Division of Molecular Diagnostics of Oncogenic Infections, German Cancer Research Center, Heidelberg, Germany;5. University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania;6. Department of Otolaryngology, Johns Hopkins University, Baltimore, Maryland;7. National Institute on Deafness and Other Communication Disorders, National Institutes of Health, Bethesda, Maryland
Abstract:
Keywords:antibody sensitivity  human papillomavirus (HPV)  human papillomavirus 16 (HPV16) E6 antibodies  recurrence  serology
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号